Contact dermatitis from levobunolol and befunolol.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000328:Adult; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis / Q000209:etiology*; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D002040:Levobunolol / Q000009:adverse effects*; D008297:Male; D009883:Ophthalmic Solutions; D010328:Patch Tests; D011412:Propanolamines / Q000009:adverse effects*
D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D011412:Propanolamines; C006034:befunolol; D002040:Levobunolol